Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 167.50
-15.50 (-8.47%)
At close: Dec 5, 2025
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 259.78 billion as of December 5, 2025. Its market cap has increased by 231.32% in one year.
Market Cap
259.78B
Enterprise Value
253.26B
Revenue
34.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
167.50
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 259.78B, an increase of 3,164.16%. That is a compound annual growth rate of 226.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 259.78B | 175.29% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 80.73B |
| Bora Pharmaceuticals Co., LTD. | 65.69B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 34.78B |
| Lumosa Therapeutics | 32.51B |
| Center Laboratories | 28.63B |
| Pegavision | 24.02B |